Clinical Trial Update: Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating ovarian response to recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• recombinant follicle-stimulating hormone (recombinant follicle-stimulating hormone)

Snippet

Sponsor: University of California, San Diego | Conditions: Polycystic Ovary Syndrome, Healthy | Phase 4 | Status: COMPLETED